Cullin 2 anticorps (N-Term)
Aperçu rapide pour Cullin 2 anticorps (N-Term) (ABIN1539078)
Antigène
Voir toutes Cullin 2 (CUL2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 150-179, N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This CUL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 150-179 amino acids from the N-terminal region of human CUL2.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000. WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- CUL2 Antibody (N-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, keep at -20 °C.
-
Date de péremption
- 6 months
-
-
- Cullin 2 (CUL2)
-
Autre désignation
- CUL2
-
Sujet
- Core component of multiple cullin-RING-based ECS (ElonginB/C-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination of target proteins. May serve as a rigid scaffold in the complex and may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1 (By similarity). The functional specificity of the ECS complex depends on the substrate recognition component. ECS(VHL) mediates the ubiquitination of hypoxia-inducible factor (HIF).
-
Poids moléculaire
- 86983
-
ID gène
- 8453
-
NCBI Accession
- NP_001185706, NP_001185707, NP_001185708, NP_003582
-
UniProt
- Q13617
-
Pathways
- M Phase, Asymmetric Protein Localization, SARS-CoV-2 Protein Interactome
Antigène
-